CellChorus
Daniel Meyer is an early stage entrepreneur and investor with experience across software, hardware and services companies in life sciences and information technology. He was the Chief Operating Officer and a board member of Genospace, an information platform for applied molecular and precision medicine, until its acquisition by HCA Healthcare (NYSE:HCA).
Dan was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc, where he covered investments in life science research products, medical device, and digital health. He was a member of the healthcare investment banking group at Credit Suisse First Boston. He holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.
This person is not in any offices
CellChorus
CellChorus® is a high-throughput platform for evaluating how individual cells move, behave and interact. The company applies visual AI to evaluate Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) videos and characterize cell behavior such as movement, activation, killing, and survival.